The effect of VSG on body weight and body fat in GLP-1r KO mice.

Slides:

Advertisements

Similar presentations

Effect of a 6-day icv ghrelin infusion (2.5 nmol/d) on cumulative food intake (A), body weight gain (B), food efficiency (C), and fat mass gain (D) Claudia.

Advertisements

GLP-1 Agonists and DPP-4 Inhibitors How do they work? Part 4.

The New Dual Glucagon-GLP-1 Agonist ZP2929 Improves Glycemic Control and Reduces Body Weight in Murine Models of Obesity and Type 2 Diabetes Jens R. Daugaard,

Volume 5, Issue 10, Pages (October 2016)

Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice.

Volume 8, Issue 3, Pages (September 2008)

Figure 1. Plasma urea concentrations in apolipoprotein E–deficient (apo-E −/−) mice with chronic renal failure (CRF). Figure 1. Plasma urea concentrations.

Volume 23, Issue 2, Pages (February 2016)

Glucose homeostasis: roles of insulin, glucagon, amylin, and GLP-1.

Volume 141, Issue 3, Pages (September 2011)

Volume 141, Issue 3, Pages e4 (September 2011)

Fig. 3. Fc fusion GDF15 molecules improve metabolic parameters in obese mice and obese cynomolgus monkeys. Fc fusion GDF15 molecules improve metabolic.

Impaired glucose tolerance in adult S1/3 KO mice on a normal chow

Body weight and oral glucose tolerance in diet-induced obese rats at 5 weeks post-surgery. Body weight and oral glucose tolerance in diet-induced obese.

Histological changes in mouse colons after DSS treatment.

A B * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 105

Volume 144, Issue 1, Pages e5 (January 2013)

Urine ammonia is highly correlated with plasma K

Decreased weight and adiposity is transmissible via the gut microbiota

Range of mean changes from baseline in body weight in clinical studies of 24–52 weeks’ duration reported in prescribing information for five GLP-1 receptor.

Cyp8b1−/− mice have an altered circulating bile acid pool.

A and B: Total caloric intake in sham rats on chow and in gastroduodenal and hepatic vagotomized rats treated with STZ with access to lard and chow. A.

A: PPG increment at week 26 for mealtime faster aspart versus IAsp.

Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.

Chronic brain insulin infusion reduces liver TG content independent of changes in body weight and food intake. Chronic brain insulin infusion reduces liver.

TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.

Transplantation of the ω3-modified microbiome as a relevant way to preserve a lean phenotype in mice fed the HFHS diet. Transplantation of the ω3-modified.

Activation of β-adrenoceptors improves glucose tolerance in diabetic animals and increases glucose uptake in vivo, ex vivo, and in vitro. Activation of.

Volume 27, Issue 11, Pages e3 (June 2019)

A: The change of plasma glucose in opioid μ-receptor knockout diabetic mice and wild-type controls receiving an oral intake of metformin (100 mg/kg). A:

FGF21 signaling in hypothalamus is blocked by FGFR1 neutralizing antibody. FGF21 signaling in hypothalamus is blocked by FGFR1 neutralizing antibody. Twelve-week-old.

Nrf2−/− mice suffered greater renal damage by STZ compared with Nrf2+/+ mice. Nrf2−/− mice suffered greater renal damage by STZ compared with Nrf2+/+ mice.

Appearance of insulin in plasma and CSF at different times after the administration of subcutaneous DET and GLAR in mice and the effect of chronic DET.

Measurement of insulin release from islets evoked by glucose, diazoxide, and high K+. Measurement of insulin release from islets evoked by glucose, diazoxide,

Plasma levels of GLP-1 are increased in patients with critical illness and correlate with disease severity. Plasma levels of GLP-1 are increased in patients.

Glucose tolerance in WT and TRPM2-KO mice.

BAFF-deficient (BAFFnull) and anti-BAFF antibody (Ab)–treated obese mice exhibit superior glucose metabolic control compared with WT and Bnull mice. BAFF-deficient.

GLP-1 and gastrin combination therapy restores normoglycemia in NOD mice. GLP-1 and gastrin combination therapy restores normoglycemia in NOD mice. Beginning.

A: Chemical structure of pterosin A

GLP-1 and gastrin combination therapy increases pancreatic insulin content (A) and β-cell mass (B) in NOD mice. GLP-1 and gastrin combination therapy increases.

ATL-801 treatment increases insulin sensitivity in KKAY mice.

Treatment of ob/ob mice with TTR-ASOs reduces adipose tissue inflammation. Treatment of ob/ob mice with TTR-ASOs reduces adipose tissue inflammation. A:

Rapid improvement of glucose tolerance induced by PP

AgRP-ATF4 KO mice have decreased food intake and enhanced energy expenditure. AgRP-ATF4 KO mice have decreased food intake and enhanced energy expenditure.

Total plasma BCAA (A) and C3 and C5 acylcarnitine (AC) (B) concentrations in the basal state and during insulin infusion in obese subjects before and after.

Subchronic glycemic effects after vehicle, metformin, SGLT2I, or combination treatment. Subchronic glycemic effects after vehicle, metformin, SGLT2I, or.

GLP-1 and gastrin combination therapy induces immunoregulatory cell activity in NOD mice. GLP-1 and gastrin combination therapy induces immunoregulatory.

Atrasentan reduces albuminuria in diabetic apoE KO mice.

(A–D) Five-hour postprandial response to breakfast (30% of total EI) within 16 diet-controlled women with GDM. The meal study took place on the research.

MϕRIP140KD mice show browning in vWAT.

Hepatic fuel metabolism in male 5αR1-KO and WT mice

Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic.

Treatment of high-fat diet–fed mice with TTR-ASOs decreases circulating TTR and RBP4 levels, and improves insulin sensitivity. Treatment of high-fat diet–fed.

Treatment of ob/ob mice with TTR-ASOs improves insulin sensitivity.

Effects of Rosi treatment on ASKO mice.

Effects of berberine on in vivo metabolism in two animal models of insulin resistance. Effects of berberine on in vivo metabolism in two animal models.

AKT thr308 phosphorylation related to total AKT2 protein in SOL muscle (m. soleus) (A) and EDL muscle (m. extensor digitorum longus) (D) and AKT ser472.

Energy stores in quadriceps muscles at rest (white bars) and after treadmill exercise (black bars) in WT and HSL KO mice. Energy stores in quadriceps muscles.

Metabolic effects of VSG in GLP-1r KO mice.

GTTs and ITTs. A: GTTs of WT (◇), LepTg (♦), Akita (open circles), and LepTg:Akita (closed circles) mice at 8 and 16 weeks of age. GTTs and ITTs. A: GTTs.

High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.

Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.

Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. Mice lacking Y1 receptor in the hematopoietic.

Study protocol. Study protocol. A: Study design. Ten candidates for RYGB were studied in an acute intervention study. All participants underwent four test.

Time course of HbA1c (A), FPG (B), body weight (C), SMPG (D), and lipase (E) from week 0 to week 26. Time course of HbA1c (A), FPG (B), body weight (C),

Tlr4−/− attenuates symptomatic parameters of gut toxicity: diarrhea and weight loss. Tlr4−/− attenuates symptomatic parameters of gut toxicity: diarrhea.

mTORC1 is required for malignant transformation in the Eμ-Myc model.

EPA+DHA supplementation does not alter body composition, body weight, or feed intake. EPA+DHA supplementation does not alter body composition, body weight,

Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.

ARQ 531 improves survival in the Eμ-TCL1 engraftment model compared with ibrutinib. ARQ 531 improves survival in the Eμ-TCL1 engraftment model compared.

Presentation transcript:

The effect of VSG on body weight and body fat in GLP-1r KO mice. The effect of VSG on body weight and body fat in GLP-1r KO mice. VSG-operated mice (n = 5 VSG; n = 7 sham) show significantly elevated plasma GLP-1 15 min after gavage of a mixed meal (A). After 5 weeks of high-fat feeding, GLP-1r WT and KO mice underwent VSG or sham surgery (n = 8 WT sham; n = 11 WT VSG; n = 12 KO sham; and n = 16 KO VSG). Body weight (B) and weight change from the time of surgery (C) were monitored, and body composition (D and E) was assessed on postoperative day 21. The food intake response to the GLP-1r agonist exendin-4 (F) is shown as the difference between 24-h food intake after exendin-4 and saline treatment. Data are represented as mean ± SEM. *P < 0.05; ***P < 0.001. Hilary E. Wilson-Pérez et al. Diabetes 2013;62:2380-2385 ©2013 by American Diabetes Association